AskTheDate.com
Back to calendar

Regeneron Pharmaceuticals, Inc. (REGN) Earnings

REGN reports earnings on Thursday, July 30, 2026

earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $10.42
Actual EPS: $9.47
EPS surprise: 6.24%
Company overview
Market Cap$68.8B
PriceUSD 656.12
P/E15.99
EPS (TTM)41.04
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410